Correction: Metformin limits osteoarthritis development and progression through activation of AMPK signalling | Annals of the Rheumatic Diseases

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Archive
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Department GEZ-LTA Erasmushogeschool

Article info

See original article:

Metformin limits osteoarthritis development and progression through activation of AMPK signalling - May 01, 2020

Correction

Correction: Metformin limits osteoarthritis development and progression through activation of AMPK signalling

Free

Citation

Correction: Metformin limits osteoarthritis development and progression through activation of AMPK signalling

Annals of the Rheumatic Diseases 2020;79:e119.

Publication history

First published August 14, 2020.

Online issue publication

August 14, 2020

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.